Private Capital Management, LLC Dia Medica Therapeutics Inc. Transaction History
Private Capital Management, LLC
- $928 Million
- Q3 2025
A detailed history of Private Capital Management, LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Private Capital Management, LLC holds 50,000 shares of DMAC stock, worth $298,000. This represents 0.04% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$298,000% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding DMAC
# of Institutions
85Shares Held
8.18MCall Options Held
19.6KPut Options Held
16.5K-
Israel Englander Millennium Management LLC | New York, Ny1.19MShares$7.08 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX875KShares$5.22 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA723KShares$4.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$4.24 Million0.0% of portfolio
-
Morgan Stanley New York, NY580KShares$3.45 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $158M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...